Are Alzheimer’s and Parkinson’s Disease Patients Taking Drugs Based on Fraudulent Research?

Finding of scientific misconduct against NIH’s National Institute on Aging: They might as well just start painting the lab mice

Science magazine this week revealed an extensive investigation into alleged fraud by  “veteran brain researcher” Dr. Eliezer Masliah, the Director of the Division of Neuroscience at the National Institute of Aging (NIA). He was appointed to that position in 2016, when Congress appropriated vast new monies for Alzheimer’s disease research; the neuroscience division received $2.6 billion in fiscal year 2023, according to Science, more than all other divisions of NIA combined. (1)

“As a leading federal ambassador to the research community and a chief adviser to NIA Director Richard Hodes, Masliah would gain tremendous influence over the study and treatment of neurological conditions in the United States and beyond,” Science said of his appointment. 

Masliah not only had the power to decide which grants to fund, thereby creating the direction of most clinical research, but he also had the power to control the paradigms of neurological diseases and freeze out—i.e., not fund—any research that…